# Impact of CYP2C19*17 on the Pharmacokinetics of Proguanil and Clopidogrel

> **NCT01456546** · PHASE1 · COMPLETED · sponsor: **University of Southern Denmark** · enrollment: 31 (actual)

## Conditions studied

- CYP2C19 Genotypes

## Interventions

- **DRUG:** Proguanil
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT01456546
- **Lead sponsor:** University of Southern Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2013-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01456546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01456546, "Impact of CYP2C19*17 on the Pharmacokinetics of Proguanil and Clopidogrel". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01456546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*